The earnings call emphasized strong revenue growth and significant improvements in service revenue and gross margins. However, challenges remain with high operating expenses, negative product margins, and a substantial net loss. The collaboration with MilliporeSigma and customer demand for GrowthDirect provide a positive outlook, though macroeconomic uncertainties persist.

Company Guidance -

Q2 2025

During the Rapid Micro Biosystems First Quarter 2025 earnings call, significant guidance was provided detailing the company's financial performance and strategic outlook. The company reported a total revenue increase of 28% to $7.2 million, marking their tenth consecutive quarter of meeting or exceeding guidance. Service revenue experienced substantial growth of 64% year over year, setting a quarterly record. Notable improvements were seen in gross margins, which increased by 33 percentage points to 6%, driven by cost reductions and manufacturing efficiencies. The company placed three GrowthRx systems in Q1, maintaining a total of 165 global placements, 146 of which are fully validated. Operating expenses decreased by 5% to $12.1 million, with a net loss of $11.3 million, improving from the previous year's loss of $13.3 million. The company reaffirmed its full-year 2025 revenue guidance of at least $32 million and provided Q2 revenue guidance ranging from $6.75 million to $7.75 million. Additionally, they anticipate completing at least 18 system validations for the year. The collaboration with MilliporeSigma is expected to enhance supply chain efficiencies and gross margin improvements, positioning the company to benefit from the anticipated expansion of U.S.-based pharmaceutical manufacturing capacities.

Revenue Growth

Total first quarter revenue increased 28% to $7.2 million, marking the tenth consecutive quarter of meeting or exceeding guidance.

Service Revenue Increase

Service revenue increased 64% year over year, setting a quarterly record.

Gross Margin Improvement

First quarter gross margins were 6%, representing a 33 percentage point improvement compared to the prior year quarter.

Successful System Placements

Three GrowthRx systems were placed in Q1, with 165 cumulative global placements, including 146 fully validated systems.

Collaboration with MilliporeSigma

Promising start to the collaboration, with global co-exclusive rights to sell the GrowthDirect system and related consumables.

Rapid Micro Biosystems (RPID) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RPID Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 01, 2025	2025 (Q2)	-0.26 / -	-0.29	―	―	―
May 09, 2025	2025 (Q1)	-0.27 / -0.26	-0.31	16.13% (+0.05)	―
Feb 28, 2025	2024 (Q4)	-0.23 / -0.22	-0.26	15.38% (+0.04)	―
Nov 01, 2024	2024 (Q3)	-0.26 / -0.26	-0.31	16.13% (+0.05)	―
Aug 02, 2024	2024 (Q2)	-0.28 / -0.29	-0.33	12.12% (+0.04)	―
May 03, 2024	2024 (Q1)	-0.29 / -0.31	-0.32	3.13% (+0.01)	―
Mar 01, 2024	2023 (Q4)	-0.30 / -0.26	-0.39	33.33% (+0.13)	―
Nov 03, 2023	2023 (Q3)	-0.31 / -0.31	-0.38	18.42% (+0.07)	―
Aug 04, 2023	2023 (Q2)	-0.34 / -0.33	-0.31	-6.45% (-0.02)	―
May 05, 2023	2023 (Q1)	-0.36 / -0.32	-0.35	8.57% (+0.03)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RPID Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 09, 2025	$2.45	$3.08	+25.71%
Feb 28, 2025	$3.31	$3.05	-7.85%
Nov 01, 2024	$1.08	$1.10	+1.85%
Aug 02, 2024	$0.68	$0.80	+17.65%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Rapid Micro Biosystems, Inc. Class A (RPID) report earnings?

Rapid Micro Biosystems, Inc. Class A (RPID) is schdueled to report earning on Aug 01, 2025, After Close (Confirmed).

What is Rapid Micro Biosystems, Inc. Class A (RPID) earnings time?

Rapid Micro Biosystems, Inc. Class A (RPID) earnings time is at Aug 01, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RPID EPS forecast?

RPID EPS forecast for the fiscal quarter 2025 (Q2) is -0.26.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing